slotkoers
Shenzhen S.E.
00:00:00 26-04-2024
|
Variatie 5 dagen
|
Verschil t.o.v. 1 jan (%)
|
23,82
CNY
|
+1,49%
|
|
+9,42%
|
-34,03%
|
Fiscaal tijdperk: december |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Marktkapitalisatie
1 |
2.816
|
3.110
|
4.225
|
7.273
|
4.322
|
4.727
|
Bedrijfswaarde
1 |
1.553
|
1.935
|
3.232
|
6.173
|
3.369
|
3.704
|
K/w-verhouding
|
29,9
x
|
49,3
x
|
-170
x
|
229
x
|
-322
x
|
-38,8
x
|
Dividendrendement
|
0,73%
|
0,53%
|
-
|
-
|
-
|
-
|
Marktkapitalisatie/omzet
|
4,77
x
|
5,01
x
|
8,06
x
|
11,8
x
|
6,28
x
|
7,85
x
|
Bedrijfswaarde/omzet
|
2,63
x
|
3,12
x
|
6,17
x
|
10
x
|
4,89
x
|
6,15
x
|
Bedrijfswaarde/EBITDA
|
12,1
x
|
26,5
x
|
-473
x
|
285
x
|
201
x
|
-98,4
x
|
Bedrijfswaarde/FCF
|
6,43
x
|
2,3
x
|
-19,5
x
|
-14,3
x
|
-27,6
x
|
-45,5
x
|
FCF Yield
|
15,6%
|
43,4%
|
-5,14%
|
-6,98%
|
-3,62%
|
-2,2%
|
Price to Book
|
1,66
x
|
1,77
x
|
2,47
x
|
3,13
x
|
1,87
x
|
2,07
x
|
Aantal aandelen (in duizenden)
|
103.355
|
103.355
|
103.355
|
122.104
|
122.104
|
130.894
|
Referentieprijs
2 |
27,25
|
30,09
|
40,88
|
59,56
|
35,40
|
36,11
|
Datum van publicatie
|
19/04/19
|
27/04/20
|
22/04/21
|
22/04/22
|
24/04/23
|
21/04/24
|
Fiscaal tijdperk: december |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Omzet
1 |
590,9
|
620,2
|
524,1
|
614,7
|
688,6
|
602,3
|
EBITDA
1 |
128,1
|
73,05
|
-6,832
|
21,69
|
16,74
|
-37,65
|
Bedrijfsresultaat (EBIT)
1 |
114,4
|
50,14
|
-35,25
|
-13,2
|
-33,66
|
-106,3
|
Operationele Marge
|
19,36%
|
8,09%
|
-6,73%
|
-2,15%
|
-4,89%
|
-17,66%
|
Resultaat voor belastingen (EBT)
1 |
105,1
|
72,61
|
-37,37
|
20,46
|
-7,824
|
-152
|
Nettowinst (verlies)
1 |
94,14
|
63,04
|
-25,03
|
27,65
|
-14,03
|
-120,8
|
Nettomarge
|
15,93%
|
10,16%
|
-4,77%
|
4,5%
|
-2,04%
|
-20,06%
|
WPA
2 |
0,9100
|
0,6100
|
-0,2400
|
0,2600
|
-0,1100
|
-0,9300
|
Free Cash Flow
1 |
241,6
|
839,4
|
-166
|
-431
|
-122,1
|
-81,37
|
FCF-marge
|
40,88%
|
135,35%
|
-31,67%
|
-70,11%
|
-17,73%
|
-13,51%
|
Kasstroomconversie (ebitda)
|
188,59%
|
1.149,03%
|
-
|
-
|
-
|
-
|
Kasstroomconversie (nettowinst)
|
256,62%
|
1.331,66%
|
-
|
-
|
-
|
-
|
Dividend per aandeel
2 |
0,2000
|
0,1600
|
-
|
-
|
-
|
-
|
Datum van publicatie
|
19/04/19
|
27/04/20
|
22/04/21
|
22/04/22
|
24/04/23
|
21/04/24
|
Fiscaal tijdperk: december |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Nettoschuldpositie
1 |
-
|
-
|
-
|
-
|
-
|
-
|
Nettokaspositie
1 |
1.264
|
1.175
|
993
|
1.100
|
954
|
1.023
|
Hefboom (schuld/ebitda)
|
-
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
1 |
242
|
839
|
-166
|
-431
|
-122
|
-81,4
|
ROE (netto-inkomsten/eigen vermogen)
|
5,46%
|
3,53%
|
-1,47%
|
1,48%
|
-0,34%
|
-5,31%
|
ROA (netto-inkomsten/totale activa)
|
3,52%
|
1,45%
|
-1,01%
|
-0,34%
|
-0,78%
|
-2,34%
|
Totale activa
1 |
2.675
|
4.350
|
2.478
|
-8.187
|
1.802
|
5.161
|
Nettoactief per aandeel
2 |
16,40
|
17,00
|
16,50
|
19,00
|
18,90
|
17,50
|
Cashflow per aandeel
2 |
2,970
|
6,730
|
4,460
|
1,510
|
6,130
|
3,590
|
Capex
1 |
38,7
|
116
|
114
|
247
|
174
|
167
|
Capex/omzet
|
6,54%
|
18,73%
|
21,68%
|
40,2%
|
25,26%
|
27,8%
|
Datum van publicatie
|
19/04/19
|
27/04/20
|
22/04/21
|
22/04/22
|
24/04/23
|
21/04/24
|
|
Vaira. 1 jan.
|
Kapi.
|
---|
| -34,03% | 430 mln. | | +25,83% | 661 mld. | | +27,00% | 566 mld. | | -6,76% | 352 mld. | | +20,34% | 332 mld. | | +3,00% | 283 mld. | | +13,09% | 231 mld. | | +5,46% | 200 mld. | | -9,61% | 195 mld. | | -6,26% | 145 mld. |
Farmaceutische producten - Andere
|